The China downstream processing market is entering a transformative phase, forecasted to reach a staggering $7,498.0 million by 2035. This growth trajectory represents a compound annual growth rate (CAGR) of approximately 16.12%, reflecting surging demand for advanced biopharmaceuticals and enhanced manufacturing processes. Such a robust forecast highlights the sector's critical role in meeting...
Bangla